Internal Memo from S J Ojala, Cutter-Miles Laboratories, to M Sternberg, re meeting with FDA, 2nd Oct 1984. Discusses core antibody testing, hepatitis warnings on product packaging, licensing of blood products, and Dr Gerety's reference to a new strain of hepatitis C that was the same as non-A non-B hepatitis.